Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia

Intensive Care Medicine

Volumn 30, Issue 5, 2004, Pages 735-738

  Yu, Victor L ^a   Singh, Nina ^a  

^a VA Healthcare VISN 4   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; LEVOFLOXACIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; EDITORIAL; GRAM NEGATIVE SEPSIS; HUMAN; INFECTION; INTENSIVE CARE UNIT; KIDNEY DISEASE; LUNG LAVAGE; MORTALITY; NEPHROTOXICITY; PENICILLIN RESISTANCE; PNEUMONIA; VENTILATOR;

ANTI-INFECTIVE AGENTS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; PNEUMONIA; RESPIRATION, ARTIFICIAL;

EID: 2442609888     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-004-2201-0     Document Type: Editorial

References (15)

1. Chinsky KD (2002) Ventilator-associated pneumonia: is there any gold in these standards? Chest 122:1883-1884
2. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505-511
3. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew RD, Suter PM (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 143:1121-1129
4. Dupont H, Montravers P, Gauzit R, Veber B, Pouriat JL (2003) Outcome of postperative pneumonia in the Eole study. Intensive Care Med 29:179-188
5. Kolleff MH (2003) Appropriate antibiotic therapy for ventilator- associated pneumonia and sepsis: a necessity, not an issue for debate. Intensive Care Med 29:147-149
6. Chastre J, Fagon JY, Soler P, et al (1988) Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of broncoalveolar lavage and the protected specimen brush. Am J Med 85:499-506
7. Dennesen PWJ, van der Ven AJAM, Kessels AJH, et al (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Crit Care Med 163:1371-1375
8. Bergmans DCJJ, Bonten MJM, Gaillard CA, van Thiel FH, van der Geest S, de Leeuw PW, Stobberingh EE (1997) Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 39:527-535
9. Singh N, Falestiny MN, Rogers P, Reed MJ, Pularski J, Norris R, Yu VL (1998) Pulmonary infiltrates in the surgical ICU. Chest 114:1129-1136
10. Kim JH, Gallis HA (1989) Observations on spiraling empiricism: its causes, allure, and perils, with particular reference to antibiotic therapy. Am J Med 87:201-206
11. Luyt CE, Chastre J, Fagon JY (2004) Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med (http://dx.doi.org/10.1007/s00134-003-2125-0)
12. Fagon J-Y, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl J-L, Sollet J-P, Tenaillon A, for the VAP Trial Group (2000) Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 132:621-630
13. Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C (2003) Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31:676-682
14. Fartoukh M, Maitre B, Honore S, Cerf C, Zahar JR, Brun-Buisson C (2003) Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 168:173-179
15. Spear S, Bowen HK (1999) Decoding the DNA of the Toyota Production System. Harvard Business Review, pp 97-106